Mårten Österlund

Mårten Österlund

Founder at MEDA AB

67 year
Health Technology
Commercial Services
Consumer Services

Profile

Mårten Österlund is the founder of Affibody AB, established in 1998, and Meda AB, established in 1999, where he holds the title of Executive VP-Business Development & Legal starting in 2014.
Dr. Österlund is also the founder of Karobio AB.
Currently, Dr. Österlund holds positions as Director at Annexin Pharmaceuticals AB, Unimedic Pharma Holding AB, Pharma Way AB, and Neobiomics AB.
In the past, he served as Co-Chief Executive Officer at Madaus GmbH.
Dr. Österlund obtained a doctorate degree from the University of Uppsala.

Mårten Österlund active positions

CompaniesPositionStart
MEDA AB Founder 1998-12-31
ANNEXIN PHARMACEUTICALS AB Director/Board Member 2020-12-31
Neobiomics AB Director/Board Member -
Pharma Way AB Director/Board Member -
Unimedic Pharma Holding AB Director/Board Member -
All active positions of Mårten Österlund

Former positions of Mårten Österlund

CompaniesPositionEnd
Karobio AB Founder -
Founder -
Chief Executive Officer -
See the detail of Mårten Österlund's experience

Training of Mårten Österlund

University of Uppsala Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mårten Österlund's experience

Connections

49

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
ANNEXIN PHARMACEUTICALS AB

Health Technology

Private companies7

Commercial Services

Health Technology

Health Technology

Karobio AB

Unimedic Pharma Holding AB

Pharma Way AB

Neobiomics AB

See company connections
  1. Stock Market
  2. Insiders
  3. Mårten Österlund